ArticleAnnals of medicine2023

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML.

Xing-Yu Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.